Synthesis of 17α-substituted ethynylestradiols: Potential ligands for drug vectors

被引:7
作者
Yaya, Amadou R. [1 ]
Touaibia, Mohamed [1 ]
Massarweh, Gassan [1 ]
Rochon, Fernande D. [1 ]
Breau, Livain [1 ]
机构
[1] Univ Quebec, Dept Chem, PharmaQAM, NanoQAM, Montreal, PQ H3C 3P8, Canada
关键词
Estradiol; Estrone derivatives; Steroid-metal complexes; Anti-cancer; MULTINUCLEAR MAGNETIC-RESONANCE; BIOLOGICAL EVALUATION; ESTROGEN-RECEPTOR; BREAST-CANCER; PLATINUM(II) COMPLEXES; CYTOTOXIC ACTIVITY; CARBOXYLATO LIGANDS; BINDING-AFFINITY; PT(II) COMPLEXES; HYBRID MOLECULES;
D O I
10.1016/j.steroids.2010.03.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
17 alpha-substituted ethynylestradiols, derived from estrone, were converted to their corresponding 17 alpha-(bromo- or iodo-propargyl)estrone intermediates. Nucleophilic substitution onto these moieties with malonate diester followed by hydrolysis and complexation with cis-Pt(Me(2)en)I-2 (Me(2)en = N,N-dimethylethylenediamine) gave cis-Pt(Me(2)en)(2-(3-(17 beta-estradiol-17 alpha-yl)-prop-2-ynyl)malonato) 7, thus demonstrating that these estrogen-derived compounds can be used to synthesize stable Pt(II) complexes. The 3-(17 beta-estradiol-17 alpha-yl)-prop-2-ynyl-1-sulfanylethylthiol 23 was also prepared. Crown Copyright (C) 2010 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:489 / 498
页数:10
相关论文
共 67 条
[1]   PRESENT OPTIMAL THERAPY IN OVARIAN-CANCER [J].
ABRAMS, J .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (01) :9-12
[2]  
Akaza H, 1994, Int J Urol, V1, P67, DOI 10.1111/j.1442-2042.1994.tb00012.x
[3]   Palladium(II) and platinum(II) complexes of (1R,2R)-(-)-1,2-diaminocyclohexane (DACH) with various carboxylato ligands and their cytotoxicity evaluation [J].
Al-Allaf, Talal A. K. ;
Rashan, Luay J. ;
Ketler, Gerhard ;
Fiebig, Heinz-Herbert ;
Al-Dujaili, Amar H. .
APPLIED ORGANOMETALLIC CHEMISTRY, 2009, 23 (05) :173-178
[4]   METAL-COMPLEXES WITH BIOLOGICALLY IMPORTANT LIGANDS .62. PLATINUM(II) COMPLEXES OF 3-(2-AMINOETHOXY)ESTRONE AND 3-(2-AMINOETHOXY) ESTRADIOL [J].
ALTMAN, J ;
CASTRILLO, T ;
BECK, W ;
BERNHARDT, G ;
SCHONENBERGER, H .
INORGANIC CHEMISTRY, 1991, 30 (21) :4085-4088
[5]   Breast Cancer, Estrogen Receptor and Ligands [J].
Bai, Zhenlin ;
Gust, Ronald .
ARCHIV DER PHARMAZIE, 2009, 342 (03) :133-149
[6]   Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes [J].
Barnes, KR ;
Kutikov, A ;
Lippard, SJ .
CHEMISTRY & BIOLOGY, 2004, 11 (04) :557-564
[7]   Design, synthesis, and biological evaluation of doxorubicin - Formaldehyde conjugates targeted to breast cancer cells [J].
Burke, PJ ;
Koch, TH .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) :1193-1206
[8]  
CARLOS SC, 2009, DALTON T, V48, P10765
[9]   Platinum(II) and technetium(I) complexes anchored to ethynylestradiol:: a way to drug targeting and delivery [J].
Cassino, C ;
Gabano, E ;
Ravera, M ;
Cravotto, G ;
Palmisano, G ;
Vessières, A ;
Jaouen, G ;
Mundwiler, S ;
Alberto, R ;
Osella, D .
INORGANICA CHIMICA ACTA, 2004, 357 (07) :2157-2166
[10]  
CHESNE C, 1986, EUR J MED CHEM, V21, P321